Press Releases

July 08 : Stentys featured in Cath Lab Digest interview of Dr Buchbinder

Mai 2008 : Mai 2008 : Interim clinical results from "OPEN I" study of the Stentys bifurcated stent reported at EuroPCR 2008 international cardiovascular meeting

Mars 2008 : Bifurcated stent company Stentys completes $18 million 'Series B' venture financing

Jan 2008 : Stentys bifurcated stent is successfully implanted for the first time at the Rotterdam ThoraxCenter

Oct 2007 : Stentys bifurcated drug-eluting stent implantation broadcasted 'live' during 'TCT2007' scientific symposium

Sep 2007 : First-in-man milestone reported for the Stentys bifurcated drug-eluting stent

Sep 2007 : Stentys appoints Hikmat Hojeibane as Chief Technology Officer

Mai 2007 : Stentys reports acute results of preclinical testing with its bifurcated stent Data presented at “EuroPCR 2007” Cardiovascular Congress

Stentys to report acute results of preclinical testing with its bifurcated stent
Data to be disclosed at “EuroPCR 2007” Cardiovascular Congress in Barcelona, Spain

April 2007 : Stentys announced today that it has appointed a Scientific Advisory Board(SAB)that includes some of the most prominent names in cardiology.

Fev 2007 : Stentys appoints Luc Morisset as Director of Regulatory Affairs

Jan 2007 : Stentys receives ‘seed’ financing from Sofinnova Partners

Sep 2006 : Stentys to present at Medtech Insight and Windhover Information’s ‘In3 Europe’ investor conference in Brussels, Sept. 18-20, 2006